MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Genetic testing transforms ADNSHL 66 care, enabling early diagnosis, personalized interventions, and aiding family planning while advancing research on hearing loss.
Explore the impact of genetic testing on managing Autosomal Dominant Nonsyndromic Hearing Loss 68. Early diagnosis, personalized care, and family insights await.
Explore how genetic testing uncovers autosomal dominant hearing loss 69, linked to the CEACAM16 gene, enhancing diagnosis, personalized care, and family planning.
Uncover the significance of genetic testing in diagnosing DFNA70. Learn about early detection, personalized treatments, and family planning for hereditary hearing loss.
Explore the role of genetic testing in diagnosing Autosomal Dominant Robinow Syndrome 3. Understand genetic mutations, family planning, and personalized treatment options.
Explore genetic testing's role in diagnosing and managing autosomal recessive cerebellar ataxia - epilepsy - intellectual disability syndrome due to TUD deficiency.
Explore the impact of genetic testing on diagnosing and managing SPG56, a rare neurodegenerative disorder, offering insights into early intervention and personalized care.
Explore genetic testing for Autosomal Recessive Early-Onset Parkinson Disease 23, aiding early diagnosis, family planning, and personalized treatments. Discover new possibilities.